GlassScriptPhysician profile
Mayson Augustus Callaway
NPI 1841653136
$8,727.28
in general payments reported to CMS, 2019-2025
21 companies · $1,375 in 2025
The $1,375 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,130 · 2022: $3,298 · 2023: $1,584 · 2024: $1,341 · 2025: $1,375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,267 · Education: $26.68 · Travel and Lodging: $5.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,267.29 |
| Education | $26.68 |
| Travel and Lodging | $5.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $2,674.72 | 2021-2024 | Senza |
| Boston Scientific Corporation | $1,995.98 | 2022-2025 | General - Pain Management |
| Medtronic, INC. | $1,843.80 | 2021-2025 | Intellis Adaptivestim, Vanta Adaptivestim |
| Abbott Laboratories | $371.34 | 2021-2025 | Proclaim |
| Globus Medical, INC. | $307.18 | 2025 | Senza |
| Spr Therapeutics, INC | $263.09 | 2022-2025 | Sprint Pns System |
| Vertos Medical, INC. | $214.51 | 2023-2024 | Mild Device Kit |
| Biotronik Nro, INC. | $197.05 | 2024-2025 | Prospera |
| Mml US, INC. | $196.75 | 2023-2025 | Reactiv8 |
| Collegium Pharmaceutical, INC. | $142.81 | 2023-2025 | Xtampza, Belbuca |
| Nalu Medical, INC. | $128.90 | 2024 | Nalu Neurostimulation System |
| Vertex Pharmaceuticals Incorporated | $86.46 | 2025 | |
| Tersera Therapeutics LLC | $70.92 | 2022 | |
| Curonix LLC | $46.07 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Saluda Medical Americas, INC. | $43.50 | 2023-2024 | Evoke, Evoke Scs |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Foundation Fusion Solutions, LLC | $37.74 | 2025 | |
| Spinal Simplicity, LLC | $26.96 | 2025 | Ha Minuteman G3-R |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.86 | 2025 | Relistor |
| Valinor Pharma, LLC | $21.33 | 2025 | Movantik |
| Si-Bone, INC. | $18.60 | 2025 | |
| International Rehabilitative Sciences, INC | $14.71 | 2025 | Rs-4i Plus With Intersperse |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mayson Callaway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.